CINECA IRIS Institutional Research Information System

VIGATO, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 322
EU - Europa 306
AS - Asia 108
SA - Sud America 5
AF - Africa 4
OC - Oceania 2
Totale 747
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 317
IT - Italia 190
SG - Singapore 63
IE - Irlanda 48
GB - Regno Unito 20
IN - India 15
HK - Hong Kong 11
SE - Svezia 11
DE - Germania 8
PT - Portogallo 8
CN - Cina 5
CZ - Repubblica Ceca 4
JP - Giappone 4
NG - Nigeria 4
CA - Canada 3
ES - Italia 3
FR - Francia 3
UA - Ucraina 3
AU - Australia 2
BR - Brasile 2
CL - Cile 2
FI - Finlandia 2
IR - Iran 2
KR - Corea 2
MX - Messico 2
NL - Olanda 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
BO - Bolivia 1
GR - Grecia 1
ID - Indonesia 1
IL - Israele 1
LV - Lettonia 1
PK - Pakistan 1
TH - Thailandia 1
Totale 747
Salva come PNG Salva come JPEG
Città #
Los Angeles 98
Turin 64
Dublin 48
Singapore 48
Chandler 32
Rome 26
Milan 25
Santa Clara 13
Nyköping 11
Ashburn 10
Lisbon 8
Lucknow 8
Bradford 6
Leeds 6
Washington 5
Abuja 4
Bad Rappenau 4
Luni 4
Medford 4
Naples 4
Princeton 4
Alessandria 3
Barcelona 3
Boardman 3
Florence 3
Garbagnate Milanese 3
Rivoli 3
Birmingham 2
Bratislava 2
Brooklyn 2
Buffalo 2
Chicago 2
Cincinnati 2
Cinisello Balsamo 2
Fort Worth 2
Gunzenhausen 2
Hradec Králové 2
Jacksonville 2
João Pessoa 2
Lake Dallas 2
Lappeenranta 2
Manchester 2
Modena 2
Montreal 2
New Hope 2
Olomouc 2
Osaka 2
Paddington 2
Parma 2
Scarborough 2
Talca 2
Vercelli 2
Wanchai 2
West Jordan 2
Alghero 1
Amsterdam 1
Bangkok 1
Bari 1
Barletta 1
Basingstoke 1
Beijing 1
Bengaluru 1
Berlin 1
Bologna 1
Borgone Susa 1
Boston 1
Caltagirone 1
Canberra 1
Candiac 1
Central 1
Cheonan 1
College Station 1
Franois 1
Gainesville 1
Gangdong-gu 1
Genzano di Roma 1
Grinzane Cavour 1
Guadalajara 1
Guangzhou 1
Islamabad 1
Jakarta 1
Jerusalem 1
Kanazawa 1
London 1
New York 1
Nice 1
Nishiōizumi 1
Noicattaro 1
Palermo 1
Polignano a Mare 1
Pune 1
Saluzzo 1
San Luis Potosí City 1
Santa Cruz 1
Seattle 1
Shanghai 1
Sydney 1
Taipei 1
Trento 1
Vaprio D'adda 1
Totale 550
Salva come PNG Salva come JPEG
Nome #
New inhibitors of Aldo-Keto Reductase 1C3 (AKR1C3) based on benzoisoxazole scaffold and their potential application in cancer 115
New Hydroxybenzoazole Inhibitors of Aldo-Keto Reductase 1C3 (AKR1C3): Disclosure of SAR Investigation to Target Prostate Cancer 85
Design of new human Dihydroorotate Dehydrogenase inhibitors: amide bioisosterism in MEDS433 optimization 82
Improvement of metabolic weakness of new human Dihydroorotate Dehydrogenase inhibitors based on 2-hydroxypyrazolo[1,5-a]pyridine scaffold 48
Targeting myeloid leukemias using human Dihydroorotate Dehydrogenase inhibitors based on 2-hydroxypyrazolo[1,5-a]pyridine scaffold: overcoming of metabolic issues 42
Targeting Acute Myelogenous Leukemia using potent human dihydroorotate dehydrogenase inhibitors based on the 2-hydroxypyrazolo[1,5-a]pyridine scaffold: from academy to clinic 36
Application of an in house bioisosteric approach to the design of innovative inhibitors of aldo-keto reductase 1C3 (AKR1C3) 35
Targeting Myeloid Leukemias Using human Dihydroorotate Dehydrogenase Inhibitors Based on 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold: Overcoming of Metabolic Issues 32
Important steps into drug development of MEDS433, a potent human dihydroorotate dehydrogenase inhibitor based on the 2-hydroxypyrazolo[1,5-a]pyridine scaffold 30
HYDROXYLATED HETEROCYCLES AS BIOISOSTERES OF THE CARBOXYLIC FUNCTION: DESIGN OF NEW AKR1C3 INHIBITORS ACTIVE IN PROSTATE CANCER 28
Important Steps into Drug Development of MEDS433, a Potent Human Dihydroorotate Dehydrogenase Inhibitor based on the 2-hydroxypyrazolo[1,5-a] Pyridine Scaffold 26
Targeting Acute Myelogenous Leukemia using potent human dihydroorotate dehydrogenase inhibitors based on the 2- hydroxypyrazolo[1,5-a]pyridine scaffold: from academy to clinic 26
Phenothiazines as anti-cancer agents: SAR overview and synthetic strategies 25
Application of an in house bioisosteric approach to the design of innovative inhibitors of aldo-keto reductase 1C3 (AKR1C3) 25
Structure-guided optimization of 3-hydroxybenzoisoxazole derivatives as inhibitors of Aldo-keto reductase 1C3 (AKR1C3) to target prostate cancer 23
A new generation of AKR1C3 inhibitors on the horizon: the 3- hydroxybenzazole approach to target prostate cancer 23
Enhancement of the metabolic stability in 2-hydroxypyrazolo[1,5-a]pyridine scaffold-based inhibitors of human dihydroorotate dehydrogenase (hDHODH) 23
Improvement of Metabolic Weakness of New Dihydroorotate Dehydrogenase Inhibitors Based on 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold to Target Myeloid Leukemias 21
AI Based Discovery of a New AKR1C3 Inhibitor for Anticancer Applications 16
Overcoming of metabolic issues in 2-hydroxypyrazolo[1,5-a]pyridine scaffold-based inhibitors of human dihydroorotate dehydrogenase: the story of MEDS700 15
Improvement of Metabolic Weakness of New Dihydroorotate Dehydrogenase Inhibitors Based on 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold to Target Myeloid Leukemias 12
Optimization of MEDS433 synthesis: scale-up for preclinical evaluation studies 12
Optimization of MEDS433 synthesis: scale-up for preclinical evaluation studies 7
Totale 787
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.393
article - articoli 0
book - libri 0
conference - conferenze 3.900
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.293
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202244 0 0 0 0 0 0 0 0 0 10 21 13
2022/2023252 22 18 12 9 10 86 29 13 16 4 15 18
2023/2024345 30 25 14 14 12 26 133 13 4 22 23 29
2024/2025146 31 41 61 13 0 0 0 0 0 0 0 0
Totale 787